The Pulmonary Alveolar Macrophage and Lung Cancer

References

• American Cancer Society. Cancer statistics, 1984. Cancer 1984; 34: 7–23
   Web of Science ®Google Scholar
• National Cancer Institute. Research report: Cancer of the lung. NIH Publication #82–526, Public Health Service US Dept. Health and Human Sciences, Bethesda, MD 1982
   Google Scholar
• US Department of Health and Human Services. The Health Consequences of Smoking: Cancer: Report of the Surgeon General. US Government Printing Office, Washington, DC 1982
   Google Scholar
• Hoffman D., Hecht S. S. Nicotine-derived N-nitrosamines and tobacco-related cancer: current status and future directions. Cancer Res 1985; 45: 935–944
   PubMed Web of Science ®Google Scholar
• Olsen G. N., Gangemi J. S. Bronchoalveolar lavage and the immunology of primary lung cancer: review. Chest 1985; 87: 677–684
   PubMed Web of Science ®Google Scholar
• Ferson M., Edwards A., Lind A., et al. Low natural killer-cell activity and immunoglobulin levels associated with smoking in human subjects. Int J Cancer 1979; 23: 603–609
   PubMed Web of Science ®Google Scholar
• Finklea J. F., Hasselbald V., Riggan W. B., et al. Cigarette smoking and hemagglutination inhibition response to influenza after natural disease and immunization. Am Rev Respir Dis 1971; 104: 368–376
   PubMed Web of Science ®Google Scholar
• Gerard J. W., Heiner P. C., Mink J., et al. Immunologlobulin levels in smokers and non-smokers. Ann Allergy 1980; 44: 261–262
   PubMedGoogle Scholar
• Gregson R. L., Prentice D. A. Aspects of the immunotoxicity of chronic tobacco smoke exposure of the rat. Toxicology 1981; 22: 23–31
   PubMed Web of Science ®Google Scholar
• Thomas W., Holt P. G., Keast D. Humoral immune response of mice with long term exposure to cigarette smoke. Arch Environ Health 1975; 30: 78–80
   PubMed Web of Science ®Google Scholar
• Daniele R. P., Dauber J. H., Altose M. J., et al. Lymphocyte studies in asymptomatic cigarette smokers. Am Rev Respir Dis 1977; 116: 997–1005
   PubMed Web of Science ®Google Scholar
• Miller L. G., Goldstein G., Murphy M., et al. Reversible alterations in immunoregulatory Tcells in smoking. Chest 1982; 82: 526–529
   PubMed Web of Science ®Google Scholar
• Petersen B. H., Steimel L. F., Callaghan J. T. Suppression of mitogen-induced lymphocyte transformation in cigarette smokers. Clin Immunol Immunopathol 1983; 27: 135–140
   PubMedGoogle Scholar
• Thomas W., Holt P. G., Keast D. Cellular immunity in mice chronically exposed to fresh cigarette smoke. Arch Environ Health 1973; 27: 372–375
   PubMed Web of Science ®Google Scholar
• Cohen A. B., Gold W. M. Defense mechanisms of the lung. Ann Rev Physiol 1975; 37: 325–350
   PubMed Web of Science ®Google Scholar
• Warr G. A., Martin R. R. Chemotactic responsiveness of human alveolar macrophages: effects of cigarette smoking. Infect Immun 1974; 9: 769–771
   PubMed Web of Science ®Google Scholar
• Warr G. A., Martin R. R. In vitro migration of human alveolar macrophages: effects of cigarette smoking. Infect Immun 1973; 8: 222–227
   PubMed Web of Science ®Google Scholar
• Harris J. O., Gonzalez-Rothi R. J. Abnormal phagolysosome fusion in pulmonary alveolar macrophages of rats exposed chronically to cigarette smoke. Am Rev Respir Dis 1984; 130: 467–471
   PubMed Web of Science ®Google Scholar
• Casio F. G., Hoidal J. R., Douglas S. D., et al. Binding of soluble immune complexes by human monocytes and pulmonary macrophages: effects of cigarette smoking. J Lab Clin Med 1982; 100: 469–476
   PubMedGoogle Scholar
• Burton R. C. Smoking, immunity and cancer. Med J Aust 1983; 411–412
   PubMed Web of Science ®Google Scholar
• Hibbs J. B., Chapman H. A., Weinberg J. B. The macrophage as an antineoplastic surveillance cell: biological perspectives. J Reticuloendothel Soc 1978; 24: 549–569
   PubMedGoogle Scholar
• Levy M. H., Wheelock E. F. The role of macrophages in defense against neoplastic disease. Adv Cancer Res 1974; 20: 131–163
   PubMedGoogle Scholar
• Keller R. Regulatory capacities of mononuclear phagocytes with particular response to natural immunity against tumors. Natural Cell-Mediated Immunity Against Tumors, R. Heberman. Academic Press, New York 1982; 1219–1269
   Google Scholar
• Panke E. A., Zwilling B. S., Somers S. D., et al. The effects of lipopolysaccharide, BCG-immune T lymphocytes and lymphokines on generation of tumoricidal pulmonary macrophages in Syrian hamster. Exp Lung Res 1982; 3: 81–90
   PubMed Web of Science ®Google Scholar
• Sone S., Fidler I. I. In vitro activation of tumoricidal properties in rat alveolar macrophages by synthetic muramyl dipeptide encapsulated in liposomes. Cell Immunol 1981; 57: 42–50
   PubMed Web of Science ®Google Scholar
• Weinberg J. B., Chapman H. A., Hibbs J. B. Characterization of the effects of endotoxin on macrophage tumor cell killing. J Immunol 1978; 121: 72–80
   PubMed Web of Science ®Google Scholar
• Bucana C., Hoyer L. C., Schiort A. J., et al. Ultrastructural studies of the interaction between liposome-activated human blood monocytes and allogenic tumor cells in vitro. Am J Pathol 1983; 112: 101–111
   PubMed Web of Science ®Google Scholar
• Hibbs J. B. Heterocytolysis by macrophages activated by Bacillus Calmette-Guerin: lysosome exocytosis into tumor cells. Science 1974; 184: 469–471
   Google Scholar
• Sone S., Fidler D. Tumor cytotoxicity of rat alveolar macrophages activated in vitro by endotoxin. J Reticuloendothel Soc 1980; 27: 269–279
   PubMedGoogle Scholar
• Carswell E. A., Old L. J., Kassel R. L., et al. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci (USA) 1975; 72: 3666–3670
   PubMed Web of Science ®Google Scholar
• Currie G. A., Basham C. Activated macrophages release a factor which lyses malignant but not normal cells. J Exp Med 1975; 142: 1600–1606
   PubMed Web of Science ®Google Scholar
• Gifford G. E., Flick D. A., Abd N. Alia, et al. Production of cytotox-in from phorbol myristate-acetate treated human promyelocytes. JNCI 1984; 73: 69–73
   PubMed Web of Science ®Google Scholar
• Mannel D. N., Moore R. N., Mergenhagen S. E. Macrophages as a source of tumoricidal activity (tumor necrotizing factor). Infect Immun 1981; 30: 523–530
   Web of Science ®Google Scholar
• Sone S., Mutsuma S., Ishii K., et al. In vitro cytotoxicity to various human tumor cell lines of a tumor cytotoxic factor(s) produced by human alveolar macrophages. Gann 1984; 75: 920–928
   PubMedGoogle Scholar
• Sone S., Tachibana K., Ishii K., et al. Production of a tumor cytolytic factor(s) by activated human alveolar macrophages and its action. Cancer Res 1984; 44: 646–651
   PubMed Web of Science ®Google Scholar
• Zacharchuk C. M., Drysdale B., Mayer M. M., et al. Macrophage-mediated cytotoxicity: role of a soluble macrophage cytotoxic factor similar to lymphotoxin and tumor necrosis factor. Proc Natl Acad Sci (USA) 1983; 80: 6341–6345
   PubMed Web of Science ®Google Scholar
• Adams D. O., Kao K., Farb R., et al. Effector mechanisms of cytolytically activated macrophages. II. Secretion of cytolytic factor by activated macrophages and its relationship to secreted neutral proteases. J Immunol 1980; 124: 293–300
   PubMed Web of Science ®Google Scholar
• Currie G. A. Activated macrophages kill tumor cells by releasing arginase. Nature 1978; 273: 758–763
   PubMed Web of Science ®Google Scholar
• Nathan C. F., Silverstein S. C., Brukner L. H., et al. Extra-cellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity. J Exp Med 1979; 149: 100–106
   PubMed Web of Science ®Google Scholar
• Kull F. C., Cuatrecassas P. Preliminary characterization of the tumor cell cytotoxin in tumor necrosis serum. J Immunol 1981; 126: 1279–1283
   PubMed Web of Science ®Google Scholar
• Mannel D. N., Falk W., Matzer M. S. Inhibition of nonspecific tumoricidal activity by activated macrophages with antiserum against a soluble cytotoxic factor. Infect Immun 1981; 33: 156–164
   PubMed Web of Science ®Google Scholar
• Ruff M., Gifford G. E. Purification and physiochemical characterization of rabbit tumor necrosis factor. J Immunol 1980; 125: 1671–1677
   PubMed Web of Science ®Google Scholar
• Shirai T., Yamaguchi H., Hirataka I., et al. Cloning and expression in Escherichia coli of the gene of human tumour necrosis factor. Nature 1985; 313: 803–806
   PubMed Web of Science ®Google Scholar
• Fransen L., Muller R., Marmenout A., et al. Molecular cloning of mouse tumor necrosis factor cDNA and its eukaryotic expression. Nucleic Acids Res 1985; 13: 4417–4429
   PubMed Web of Science ®Google Scholar
• Vose B. M. Cytotoxicity of adherent cells associated with some human tumors and lung tissues. Cancer Immunol Immunother 1978; 5: 173–179
   Web of Science ®Google Scholar
• Yanagawa E., Yatsumoto K., Manabe H., et al. Cytostatic activity of peripheral blood monocytes against bronchogenic carcinoma cells in patients with lung cancer. Gann 1979; 70: 533–539
   PubMedGoogle Scholar
• Hisano G., Oguchi H., Nakayama T., et al. Cytotoxic activity of human alveolar macrophages against human lung cancer cell line II. Proc Jpn Cancer Assoc 1980; 125–129
   Google Scholar
• Bordignon C., Avallone R., Peri G., et al. Cytotoxicity on tumor cells of human mononuclear phagocytes: defective tumoricidal capacity of alveolar macrophages. Clin Exp Immunol 1980; 41: 336–342
   PubMed Web of Science ®Google Scholar
• Lemarbre P., Hoidal J., Vesella R., et al. Human pulmonary macrophage tumor cell cytotoxicity. Blood 1980; 55: 612–617
   PubMed Web of Science ®Google Scholar
• Swinburne S., Moore M., Cole P. Human bronchoalveolar macrophage cytotoxicity for cultured human lung-tumor cells. Br J Cancer 1982; 46: 625–634
   PubMed Web of Science ®Google Scholar
• Sone S., Moriguchi S., Shimizu E., et al. In vitro generation of tumoricidal properties in human alveolar macrophages following interaction with endotoxin. Cancer Res 1982; 42: 2227–2231
   PubMed Web of Science ®Google Scholar
• Kan-Mitchell J., Hengst J. C., Kempf R. A., et al. Cytotoxic activity of human pulmonary alveolar macrophages. Cancer Res 1985; 45: 453–458
   PubMed Web of Science ®Google Scholar
• Nakahashi H., Yasumoto K., Nagashima A., et al. Antitumor activity of macrophages in lung cancer patients with special reference to location of macrophages. Cancer Res 1984; 44: 5906–5909
   PubMed Web of Science ®Google Scholar
• Rhodes J., Plowman P., Bishop M., et al. Human macrophage function in cancer: systemic and local changes detected by an assay for Fc receptor expression. JNCI 1981; 66: 423–429
   PubMed Web of Science ®Google Scholar
• Renoux G., Lemaire E., Legrand M. F., et al. Pulmonary alveolar macrophage chemotaxis in malignant tumors of the lung. Adv Exp Med Biol 1982; 155: 361–367
   PubMed Web of Science ®Google Scholar
• Lemaire E., Carre P., Legrand M. F., et al. Alveolar macrophage dysfunction in malignant lung tumors. Thorax 1984; 39: 448–452
   PubMed Web of Science ®Google Scholar
• Pace J. L., Russell S. W., LeBlanc P. A., et al. Comparative effects of various classes of mouse interferons on macrophage activation for tumor cell killing. J Immunol 1985; 134: 977–981
   PubMed Web of Science ®Google Scholar
• Keller R. Macrophages in primary and secondary tumor growth: some implications for cancer therapy. Biomed Pharmacother 1985; 39: 7–12
   PubMed Web of Science ®Google Scholar
• Flick D. A., Gonzalez-Rothi R. J., Harris J. O., et al. Rat lung macrophage tumor cytotoxin production: impairment by chronic in vivo cigarette smoke exposure. Cancer Res 1985; 45: 5225–5229
   PubMed Web of Science ®Google Scholar